Impact of Pembrolizumab Versus Chemotherapy on Health-Related Quality of Life in Patients With Metastatic Triple-Negative Breast Cancer: Results From the Phase 3 Randomized KEYNOTE-119 Study

We report results of prespecified health-related quality of life (HRQoL) analyses from KEYNOTE-119.

Source: European Journal of Cancer - October 20, 2023 Category: Cancer & Oncology Authors: Peter Schmid, Oleg Lipatov, Seock-Ah Im, Anthony Goncalves, Eva Mu ñoz-Couselo, Keun Seok Lee, Kenji Tamura, Laura Testa, Isabell Witzel, Shoichiro Ohtani, Nicholas Turner, Stefania Zambelli, Nadia Harbeck, Fabrice Andre, Rebecca Dent, Jaime A. Mejia, Xu Tags: Original Research Source Type: research